Literature DB >> 16465464

A transitory activation of protein kinase-A induces a sustained tau hyperphosphorylation at multiple sites in N2a cells-imply a new mechanism in Alzheimer pathology.

Y Zhang1, H-L Li, D-L Wang, S-J Liu, J-Z Wang.   

Abstract

Overactivation of protein kinase in the end stage of Alzheimer's disease brain has not been established. The purpose of the present study was to explore the possible mechanism for protein kinases in leading to Alzheimer-like tau hyperphosphorylation. We found that incubation of N2a/tau441 with forskolin, a specific activator of cAMP-dependent protein kinase (PKA), induced an increased phosphorylation level of tau at both PKA and non-PKA sites in a dose- and time-dependent manner, and the hyperphosphorylation of tau was positively correlated with the elevation of PKA activity. When the cells were transitorily incubated with forskolin, a temporary activation of PKA with a sustained and almost equally graded tau hyperphosphorylation at some non-PKA sites was observed. In either case, the activity of glycogen synthase kinase-3 (GSK-3) was not changed. It is suggested that only transitory activation of PKA in early stage of Alzheimer disease may result in a sustained tau hyperphosphorylation at multiple sites, implying a new mechanism to Alzheimer-like tau hyperphosphorylation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16465464     DOI: 10.1007/s00702-005-0421-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  32 in total

1.  Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase.

Authors:  B E Kemp; D J Graves; E Benjamini; E G Krebs
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

Review 2.  Alzheimer's disease: a cell biological perspective.

Authors:  K S Kosik
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

3.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Authors:  I Grundke-Iqbal; K Iqbal; Y C Tung; M Quinlan; H M Wisniewski; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 4.  Tau protein phosphorylation as a therapeutic target in Alzheimer's disease.

Authors:  Lit-Fui Lau; Joel B Schachter; Patricia A Seymour; Mark A Sanner
Journal:  Curr Top Med Chem       Date:  2002-04       Impact factor: 3.295

Review 5.  Post-translational modifications of tau protein in Alzheimer's disease.

Authors:  C-X Gong; F Liu; I Grundke-Iqbal; K Iqbal
Journal:  J Neural Transm (Vienna)       Date:  2004-10-27       Impact factor: 3.575

6.  Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory.

Authors:  Shi Jie Liu; Ai Hong Zhang; Hong Lian Li; Qun Wang; Heng Mei Deng; William J Netzer; Huaxi Xu; Jian Zhi Wang
Journal:  J Neurochem       Date:  2003-12       Impact factor: 5.372

Review 7.  Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action?

Authors:  A Laurenza; E M Sutkowski; K B Seamon
Journal:  Trends Pharmacol Sci       Date:  1989-11       Impact factor: 14.819

Review 8.  Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion.

Authors:  Khalid Iqbal; Alejandra del C Alonso; Ezzat El-Akkad; Cheng-Xin Gong; Niloufar Haque; Sabiha Khatoon; Jin-Jing Pei; Ichiro Tsujio; Jian-Zhi Wang; Inge Grundke-Iqbal
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

Review 9.  Role of tau protein in both physiological and pathological conditions.

Authors:  Jesus Avila; Jose J Lucas; Mar Perez; Felix Hernandez
Journal:  Physiol Rev       Date:  2004-04       Impact factor: 37.312

10.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.

Authors:  E Braak; H Braak; E M Mandelkow
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more
  5 in total

Review 1.  Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.

Authors:  Michy P Kelly
Journal:  Cell Signal       Date:  2017-11-23       Impact factor: 4.315

2.  Forskolin Induces Hyperphosphorylation of Tau Accompanied by Cell Cycle Reactivation in Primary Hippocampal Neurons.

Authors:  Hai-Hong Wang; Yan Li; Ang Li; Fang Yan; Zhen-Lin Li; Zhong-Ying Liu; Lei Zhang; Jian Zhang; Wei-Ren Dong; Lin Zhang
Journal:  Mol Neurobiol       Date:  2016-12-19       Impact factor: 5.590

3.  PINK1 overexpression prevents forskolin-induced tau hyperphosphorylation and oxidative stress in a rat model of Alzheimer's disease.

Authors:  Xiao-Juan Wang; Lin Qi; Ya-Fang Cheng; Xue-Fei Ji; Tian-Yan Chi; Peng Liu; Li-Bo Zou
Journal:  Acta Pharmacol Sin       Date:  2021-12-10       Impact factor: 7.169

4.  Estradiol attenuates tau hyperphosphorylation induced by upregulation of protein kinase-A.

Authors:  Xin-An Liu; Ling-Qiang Zhu; Qi Zhang; Hai-Rong Shi; Shao-Hui Wang; Qun Wang; Jian-Zhi Wang
Journal:  Neurochem Res       Date:  2008-03-13       Impact factor: 3.996

Review 5.  Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work.

Authors:  Rajesh Kumar; Seetha Harilal; Sheeba Varghese Gupta; Jobin Jose; Della Grace Thomas Parambi; Md Sahab Uddin; Muhammad Ajmal Shah; Bijo Mathew
Journal:  Eur J Med Chem       Date:  2019-08-08       Impact factor: 6.514

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.